期刊文献+

成功行经皮球囊二尖瓣成形术后功能性三尖瓣反流的远期随访 被引量:1

Long Term Outcome for Functional Tricuspid Regurgitation in Patients After Successful Percutaneous Balloon Mitral Valvuloplasty
下载PDF
导出
摘要 目的:了解二尖瓣狭窄经皮球囊二尖瓣成形术(PBMV)后功能性三尖瓣反流(FTR)的远期变化情况。方法:人选自2000-01至2012—01我院成功完成PBMV764例连续病例,术前FTR≤2级为轻度,FTR≥3级为中重度。每1年门诊随访一次,将FTR仍为0级或减轻至少1级(重度FTR减轻至少2级)的患者称为逆转组,将FTR未减轻(FTR为0级除外)或加重或FTR≥3级的患者称为未逆转组。采用Cox多因素回归分析FTR未逆转的影响因素。结果:764例成功完成PBMV的患者随访1年内、1—3年、3~5年、5年以上FTR程度较术前均有明显改善(P均〈O.01),但中重度FTR(反流≥3级)患者在随访期间所占随访人群比例呈增加趋势(分别为7.1%、8.7%、15.8%、19.O%)。随访结束时,轻度FTR患者中逆转组逆转比率略高于中重度FTR患者(54.9%与46.1%,P〈0.05),发生≥3级FTR患者明显低于中重度TFR患者(3.1%与53.9%,P〈0.001)。Cox多因素回归分析显示在轻度患者中,心房颤动(房颤)、再狭窄为患者成功PBMV后FTR未逆转的预测因素;在中重度患者中,房颤、术前伴重度FTR及再狭窄为成功PBMV后FTR未逆转的预测因素。结论:大多数二尖瓣狭窄伴FTR≤2级的患者成功PBMV后FTR长期稳定于轻度及轻度以下;二尖瓣狭窄伴FTR≥3级的患者成功PBMV后应长期监测FTR进展情况,尤其对于合并房颤、术前伴重度FTR患者,FTR的进展与再狭窄密切相关。 Objective: To explore the long term outcome for functional tricuspid regurgitation (FTR) in patients after successful percutaneous balloon mitral valvuloplasty (PBMV). Methods: We retrospectively studied 764 consecutive patients with mitral stenosis (MS) and received successful PBMV in our hospital from 2000 to 2012. The patients with pre-PBMV FTR≤2 degree was defined as mild level, pre-PBMV FTR 3 degree as moderate to severe level. The patients were followed-up once per year and divided into 2 groups, Reversion group, in which the patients had FTR at still 0 or regressed I〉 1 degree (the patients at severe level FTR regressed at least ≤2 degree) and No-reversion group, in which the patients had FTR unchanged, aggravated or ≤ 3 degree. Multivariate Cox regression analysis was conducted to study the influencing factors for FTR no-reversion. Results: With 1, 1-3, 3-5 and more than 5 years of follow-up, FTR obviously improved than they were before the operation, all P〈0.01, in patients at moderate to severe level, FTR increased for 7.1%, 8.7%, 15.8% and 19.0% respectively. By the end of follow-up time, the FTR reversion rate in mild patients was higher than that in moderate to severe patients,54.9% vs 46.1%, P〈0.05. The incidence for having morderate to severe FTR in mild patients was less than moderate to severe patients, 3.1% vs 53.9%, P〈0.001. Multivariate Cox regression analysis showed that in mild patients, atrial fibrillation (AF) and restenosis were the predictors for FTR no-reversion after PBMV, in moderate to severe patients, AF, severe TR before the operation and restenosis were the predictors for FTR no-reversion after PBMV. Conclusion: Successful PBMV in most MS patients with FTR ~〈2 degree before operation could maintain a stable mild or better than mild FTR condition, long term monitoring is necessary for patients with FTR ≥ 3 degree before operation. The progress of FTR after PBMV is related to AF and restenosis.
出处 《中国循环杂志》 CSCD 北大核心 2013年第7期532-536,共5页 Chinese Circulation Journal
关键词 经皮球囊二尖瓣成形术 三尖瓣反流 Percutaneous balloon mitral valvuloplasty Tricuspid regurgitation
  • 相关文献

参考文献14

  • 1Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coil Cardiol, 2004, 43: 405-409.
  • 2Mugge A, Daniel WG, Hermann G. Quantification of tricuspid regurgitation by Doppler color flow mapping after cardiac transplantation. Am J Cardiol, 1990, 66: 884-887.
  • 3Song JM, Kang DH, Song JK, et al. Outcome of significant functional tricuspid regurgitation after percutaneous mitral valvuloplasty. Am Heart J, 2003, 145: 371-376.
  • 4Hannoush H, Fawzy ME, Stefadouros M, et al. Regression of significant tricuspid regurgitation after mitralballoon valvotomy for severe mitral stenosls. Am Heart J, 2004, 148: 865-870.
  • 5Song H, Kang DH, Kim JH, et al. Percutaneous mitralvalvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation, 2007, 116 (11 Suppl) : I246-I250.
  • 6Sagie A, Schwammenthal E, Palacios IF, et al. Significant tricuspid regurgitation does not resolve after percutaneous balloon mitral valvotomy. J Thorac Cardiovasc Surg, 1994, 108: 727-735.
  • 7Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coil Cardiol, 1994, 24: 696-702.
  • 8Lee SP, Kim HK, Kim KH, et al. Prevalence of significant tricuspid regurgitation in patients with successful percutaneous mitral valvuloplasty for mitral stenosis: results from 12 years' follow-up of one centre prospective Registry. Heart, 2013, 99: 91-97.
  • 9Spinner EM, Shannon P, Buice D, et al. In vitro characterization of the mechanisms responsible for functional tricuspid regurgitation. Circulation, 2011, 124: 920-929.
  • 10Kin HK, Kim YJ, Kim KI, et al. Impact of the maze operation combined with left-sided valve surgery on the change in tricuspid regurgitation over time. Circulation, 2005, 112 (9 Suppl) : I14 - I19.

二级参考文献23

  • 1崔炜,黄连军,荆宝莲,戴汝平,徐仲英,蒋世良,谢若兰.经皮二尖瓣球囊扩张术对右心功能的影响[J].中华心血管病杂志,1994,22(5):344-346. 被引量:11
  • 2Braunwald NS,Ross J,Morrow AG.Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement.Circulation,1967,35:163-169.
  • 3Matsuyama K,Matsumoto M,Sugita T,et al.Predictors of residual tricuspid regurgitation after mitral valve surgery.Ann Thorac Surg,2003,75:1826-1828.
  • 4Bernal JM,Morales D,Revuelta C,et al.Reoperations after tricuspid valve repair.J Thorac Cardiovasc Surg,2005,130:498-503.
  • 5Bonow RO,Carabello B,de Leon AC,et al.ACC/AHA guidelines for the management of patients with valvular heart disease.Executive Summary.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease).J Heart Valve Dis,1998,7:672-707.
  • 6Carrier M,Pellerin M,Guertin MC,et al.Twenty-five years' clinical experience with repair of tricuspid insufficiency.J Heart Valve Dis,2004,13(6):952-956.
  • 7Ghanta RK,Chen R,Narsyanasamy N,et al.Suture bicuspidization of the tricuspid valve versus ring annuloplaaty for repair of functional tricuspid regurgitation:midterm results of 237 consecutive patients.J Thorac Cardiovasc Surg,2007,133(1):117-126.
  • 8McCarthy PM,Bhudia SK,Rajaswaran J,et al.Tricuspid valve repair:durability and risk factors for failure.J Thorac Cardiovasc Surg.2004; 127:674-685.
  • 9Tang GH,David TE,Singh SK,et al.Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes.Circulation,2006,114(1 Suppl):I577-581.
  • 10Matsuyama K,Matsumoto M,Sugita T,et al.De Vega annuloplasty and Carpentier-Edwards ring annuloplasty for secondary tricuspid regurgitation.J Heart Valve Dis,2001,10(4):520-4.

共引文献17

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部